FOXO TECHNOLOGIES INC. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- FOXO TECHNOLOGIES INC. stock issued during period, value, conversion of units for the quarter ending 2025-09-30 was $963.97K.
- FOXO TECHNOLOGIES INC. stock issued during period, value, conversion of units for the quarter ending 2025-06-30 was $1.06M.
- FOXO TECHNOLOGIES INC. stock issued during period, value, conversion of units for the quarter ending 2025-03-31 was $828.47K.
- FOXO TECHNOLOGIES INC. stock issued during period, value, conversion of units for fiscal 2025 was $3.02M, a 334.03% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. stock issued during period, value, conversion of units for fiscal 2024 was $694.75K.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2025-12-31 | $3.02M 10-K · filed 2026-04-15 | |
| 2025-09-30 | $963.97K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.06M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $828.47K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $694.75K 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |